International Sales Reach Record Mix, Yet Core Thesis Unchanged

What happened

Revolve reported a 16% increase in international sales, pushing international mix to a record 23% of total revenue. The growth was broad-based across regions, consistent with prior quarters where international outperformed domestic. However, this does not offset the deceleration in total net sales growth, which fell from 10% in Q1 2025 to mid-single digits recently. Despite the international momentum, the stock trades at ~37x EPS and ~32x EV/EBITDA, embedding expectations for sustained mid-single-digit growth and elevated margins. The market may view this as a positive, but tariff risks, soft U.S. demand, and margin pressure from value-seeking consumers remain key concerns.

Implication

Investors should recognize that while international expansion is a key bull thesis, at 23% of sales it is not yet large enough to offset domestic weakness and tariff exposure. The 16% international growth rate, while solid, is not accelerating enough to shift the overall revenue growth trajectory from mid-single digits. Additionally, the company's gross margin benefits from owned brands and mix, but macro pressures and potential tariff increases could erode that advantage. At current valuation, the market is paying a premium for a margin story that may face headwinds; the risk/reward skews negative unless growth re-accelerates or tariffs ease. Thus, we maintain a cautious outlook: existing holders should trim on strength, and new investors should wait for a more attractive entry near $22.

Thesis delta

The news confirms the international growth pillar but does not materially change the investment thesis. While it supports the bull case for diversification, it does not address the core concerns of decelerating total growth and margin risk. Therefore, no shift in rating or valuation outlook is warranted at this time.